Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 141
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT03743740 The Effect of Spinal Stabilization Exercises in Patients With Myastheni… |
The Effect of Spinal Stabilizatio… | Myasthénie | NA | COMPLETED | En attente / non publié | Hacettepe University | Turkey (Türkiye) · Hacettepe University, Ankara, Turk… | 2018-12-03 → 2019-04-08 | Ouvrir |
| NCT01825395 Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome |
3, 4-Diaminopyridine | Myasthénie | À vérifier | APPROVED_FOR_MARKETING | En attente / non publié | University of Colorado, Denver | United States · University of Colorado, Aurora, Unite… | Non communiqué | Ouvrir |
| NCT07337395 Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab |
Proteomic Changes in Patients Wit… | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Fondazione Policlinico Universita… | Italy · Fondazione Policlinico Universitario A. Gemel… | 2026-01 → 2028-01 | Ouvrir |
| NCT07085676 Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases |
HBI0101 CART | Myasthénie | Phase 1 | RECRUITING | En attente / non publié | Polina Stepensky | Israel · Hadassah MO, Jerusalem, Israel | 2024-09-01 → 2030-11-01 | Ouvrir |
| NCT04346888 A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG… |
HBM9161 Injection (680mg and 340 … | Myasthénie | Phase 2 | COMPLETED | En attente / non publié | Harbour BioMed (Guangzhou) Co. Lt… | China · Huashan Hospital, Fudan University, Shanghai,… | 2020-07-23 → 2021-08-24 | Ouvrir |
| NCT07291713 Psychological Health and Adverse Childhood Experiences in Myasthenia Gr… |
Psychological Health and Adverse … | Myasthénie | NA | COMPLETED | En attente / non publié | Jiann-Horng Yeh | Taiwan · Shin Kong Wu Ho-Su Memorial Hospital, Taipei… | 2024-01-10 → 2025-01-09 | Ouvrir |
| NCT03304054 Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG |
Amifampridine Phosphate | Myasthénie | Phase 3 | COMPLETED | En attente / non publié | Catalyst Pharmaceuticals, Inc. | United States · Cleveland Clinic, Cleveland, United S… | 2018-04-18 → 2020-03-15 | Ouvrir |
| NCT07226830 Quantification of Change in MG Disease Activity in Individuals With Gen… |
Quantification of Change in MG Di… | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | BioSensics | United States · Massachusetts General Hospital, Neuro… | 2026-01-15 → 2028-03-31 | Ouvrir |
| NCT05868837 Rituximab EfFicacy IN MyasthEnia Gravis (REFINE) |
Rituximab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | Italy · Policlinico A. Gemelli IRCCS, Roma, Italy | 2022-02-28 → 2025-07-31 | Ouvrir |
| NCT02473965 Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With… |
IGIV-C | Myasthénie | Phase 2 | COMPLETED | En attente / non publié | Grifols Therapeutics LLC | United States, Belgium, Canada, Czechia, Estonia, Fra… | 2015-06 → 2019-02 | Ouvrir |
| NCT07333196 Tongji NADs Cohort |
Tongji NADs Cohort | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Tongji Hospital | China · Tongji Hospital of Tongji Medical College, Hu… | 2026-03-01 → 2037-03-01 | Ouvrir |
| NCT03792659 The EXPLORE MG Registry for Myasthenia Gravis |
The EXPLORE MG Registry for Myast… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Yale University | United States · Yale-New Haven Hospital, New Haven, U… | 2016-03-30 → 2026-10-30 | Ouvrir |
| NCT06939166 Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Target… |
UCAR T-cell | Myasthénie | Phase 1 | RECRUITING | En attente / non publié | Tianjin Huanhu Hospital | China · Tianjin Huanhu Hospital, Tianjin, China | 2025-06-17 → 2027-10 | Ouvrir |
| NCT00727194 Safety and Efficacy Study of Eculizumab in Patients With Refractory Gen… |
eculizumab | Myasthénie | Phase 2 | TERMINATED | En attente / non publié | Alexion Pharmaceuticals, Inc. | United States, Canada, United Kingdom · Caritas St. E… | 2008-10 → 2011-07 | Ouvrir |
| NCT06624345 Interval Inspiratory Training and Aerobic Exercise for Muscle Recovery … |
Inspiratory muscle training | Myasthénie | NA | COMPLETED | En attente / non publié | Chang Gung University | Taiwan · Kaohsiung Chang Gung Memorial Hospital, Kaoh… | 2018-01-01 → 2018-12-31 | Ouvrir |
| NCT04226170 Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Pos… |
DAS-001 | Myasthénie | Phase 2 | TERMINATED | En attente / non publié | DAS-MG, Inc | United States · University of Kansas Medical Center, … | 2023-11-08 → 2025-04-30 | Ouvrir |